מדינה: קפריסין
שפה: יוונית
מקור: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας
CLARITHROMYCIN
DELORBIS PHARMACEUTICALS LTD (0000009620) 17 ATHINON STREET, ERGATES INDUSTRIAL AREA, LEFKOSIA, 2081, 28629
J01FA09
CLARITHROMYCIN
250MG
FILM COATED TABLETS
CLARITHROMYCIN (8000001318) 250MG
ORAL USE
Εθνική Διαδικασία
CLARITHROMYCIN
Νομικό καθεστώς: Με Ιατρική Συνταγή; PACK WITH 14 TABS IN BLISTER(S) (980006801) 14 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή
COMPARATIVE TABLE OF PIL-EN VS PIL-GR PACKAGE LEAFLET: INFORMATION FOR THE PATIENT CLERON 250 MG FILM-COATED TABLETS CLERON 500 MG FILM-COATED TABLETS clarithromycin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Cleron tablets are and what they are used for 2. What you need to know before you take Cleron tablets 3. How to take Cleron tablets 4. Possible side effects 5. How to store Cleron tablets 6. Contents of the pack and other information 1. WHAT CLERON TABLETS ARE AND WHAT THEY ARE USED FOR ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ: ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΤΟΝ ΑΣΘΕΝΉ CLERON 250 MG ΕΠΙΚΑΛΥΜΜΈΝΑ ΜΕ ΛΕΠΤΌ ΥΜΈΝΙΟ ΔΙΣΚΊΑ CLERON 500 MG ΕΠΙΚΑΛΥΜΜΈΝΑ ΜΕ ΛΕΠΤΌ ΥΜΈΝΙΟ ΔΙΣΚΊΑ κλαριθρομυκίνη ΔΙΑΒΆΣΤΕ ΠΡΟΣΕΚΤΙΚΆ ΟΛΌΚΛΗΡΟ ΤΟ ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ ΠΡΙΝ ΑΡΧΊΣΕΤΕ ΝΑ ΠΑΊΡΝΕΤΕ ΑΥΤΌ ΤΟ ΦΆΡΜΑΚΟ, ΔΙΌΤΙ ΠΕΡΙΛΑΜΒΆΝΕΙ ΣΗΜΑΝΤΙΚΈΣ ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΣΑΣ. Φυλάξτε αυτό το φύλλο οδηγιών χρήσης. Ίσως χρειαστεί να το διαβάσετε ξανά. Εάν έχετε περαιτέρω απορίες, ρωτήστε τον γιατρό ή τον φαρμακοποιό σας. Η συνταγή για αυτό το φάρμακο χορηγήθηκε αποκλειστικά για σας. Δεν πρέπει να δώσετε το φάρμακο σε ά קרא את המסמך השלם
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Cleron 250 mg Film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 250 mg of Clarithromycin. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablets. Cleron 250 mg Film-coated tablets are yellow, round, concave film coated tablets, 12mm in diameter, scored on one side and embossed with “CLERON 250”. 4. CLINICAL INFORMATION 4.1 THERAPEUTIC INDICATIONS Consideration should be given to official guidance on the appropriate use of antibacterial agents. Cleron 250 mg film-coated tablets are indicated in adults and children 12 years and older. Clarithromycin is indicated for treatment of infections caused by susceptible organisms. Indications include: Lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia (see section 4.4 and 5.1 regarding Sensitivity Testing). Upper respiratory tract infections for example, sinusitis and pharyngitis. Clarithromycin is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active _in vitro_ against common and atypical respiratory pathogens as listed in the microbiology section. Clarithromycin is also indicated in skin and soft tissue infections of mild to moderate severity (e.g. folliculitis, cellulitis, erysipelas) (see section 4.4 and 5.1 regarding Sensitivity Testing). Clarithromycin in the presence of acid suppression effected by omeprazole or lansoprazole is also indicated for the eradication of _H. pylori_ in patients with duodenal ulcers. See Dosage and Administration section. 1 Clarithromycin is usually active against the following organisms in vitro: Gram-positive Bacteria: _Staphylococcus aureus_ (methicillin susceptible); _Streptococcus pyogenes_ (Group A beta-haemolytic streptococci); alpha-haemolytic streptococci (viridans group_); Streptococcus_ _(Diplococcus) pneumoniae; Streptococcus agalactiae; Listeria monocytogenes_. Gram-negative Bacter קרא את המסמך השלם